Abstract
43P - A phase I-II clinical trial to evaluate the safety, pharmacokinetics and efficacy of high dose intravenous ascorbic acid synergy with mEHT in Chinese patients with stage III-IV non-small cell lung cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have